Dr. Goldenberg is the associate dean for clinical and translational research and director of the Johns Hopkins All Children's Institute for Clinical and Translational Research. He is the Perry Family Endowed Professor in Clinical and Translational Research and a professor of pediatrics and medicine at the Johns Hopkins University School of Medicine.
Dr. Goldenberg also serves as chief research officer for All Children’s Research Institute. He directs the Thrombosis Program in the Johns Hopkins All Children’s Cancer and Blood Disorders Institute and the Stroke Program in the Johns Hopkins All Children’s Institute for Brain Protection Sciences. Dr. Goldenberg is an international leader in the field of venous thromboembolism in children and young adults.
Dr. Goldenberg is the principal investigator for the National Institutes of Health-sponsored Kids-DOTT trial. He also serves as principal investigator for two grant-funded prospective cohort and bio banking studies at Hopkins that strongly align with institutional research priorities for pediatric research: the Institution-wide Prospective Inception Cohort Study of Individuals with Childhood-Onset Acute and Chronic Health Conditions (iPICS) and the Prospective Research on Early Determinants of Illness and Children's Health Trajectories (PREDICT)—the latter in partnership with Baltimore-based Johns Hopkins University faculty colleague Sara Johnson, Ph.D., who serves as principal investigator on an NIH grant for the study.
Dr. Goldenberg serves as a member of steering committees and data and safety monitoring committees for several NIH- and pharmaceutical industry-sponsored multicenter clinical trials, and has co-authored numerous international clinical and clinical research guidelines in pediatric thrombosis and stroke. He is also the chair of the Pediatric Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Dr. Goldenberg earned his medical degree from McGill University Faculty of Medicine in Montreal, Quebec. He completed a pediatric residency from the University of South Florida in Tampa, Florida, followed by a fellowship in hematology/oncology from the University of Colorado in Denver. Dr. Goldenberg holds a Ph.D. in Clinical Investigation from the University of Colorado.
Before joining Johns Hopkins All Children’s, Dr. Goldenberg was on the faculty of the University of Colorado School of Medicine and served as director of the Children's Clinical Research Organization and co-director of the pediatric thrombosis and stroke programs at Children's Hospital Colorado. He also directed the Department of Clinical Science and Safety at CPC Clinical Research, a university-affiliated Academic Research Organization that runs NIH- and pharma-sponsored clinical trials.
Dr. Goldenberg has authored more than 160 original research reports, review articles and book chapters, mostly as first or senior author. He is also the co-editor of a definitive textbook from Cambridge University Press on pediatric thrombotic disorders.